title: [Kasabach-Merritt phenomenon (KMP) exacerbated by platelet transfusions].
authors.affiliation: Unité de dermatologie pédiatrique, service de dermatologie, CHRU, 37044 Tours cedex 9, France; Service de dermatologie-vénéréologie, CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso. Electronic address: nessine2000@yahoo.fr.
authors.forename: N
authors.initials: N
authors.lastname: Korsaga-Somé
authors.affiliation: Unité de dermatologie pédiatrique, service de dermatologie, CHRU, 37044 Tours cedex 9, France; Université François-Rabelais, 60, rue du Plat-D'Étain, 37000 Tours, France.
authors.forename: A
authors.initials: A
authors.lastname: Maruani
authors.affiliation: Unité de dermatologie pédiatrique, service de dermatologie, CHRU, 37044 Tours cedex 9, France.
authors.forename: I
authors.initials: I
authors.lastname: Abdo
authors.affiliation: Université François-Rabelais, 60, rue du Plat-D'Étain, 37000 Tours, France; Unité de néonatalogie et soins intensifs, service de réanimation pédiatrique et néonatalogie, CHRU, 37044 Tours cedex 9, France.
authors.forename: G
authors.initials: G
authors.lastname: Favrais
authors.affiliation: Unité de dermatologie pédiatrique, service de dermatologie, CHRU, 37044 Tours cedex 9, France; Université François-Rabelais, 60, rue du Plat-D'Étain, 37000 Tours, France.
authors.forename: G
authors.initials: G
authors.lastname: Lorette
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D001365:Axilla; D003131:Combined Modality Therapy; D058128:Compression Bandages; D018450:Disease Progression; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D004630:Emergencies; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006390:Hemangioendothelioma / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006417:Hematuria / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D059885:Kasabach-Merritt Syndrome / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D010976:Platelet Count; D017713:Platelet Transfusion / Q000009:adverse effects*; D011433:Propranolol / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D012878:Skin Neoplasms / Q000151:congenital* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy
chemical_list: D011433:Propranolol; D001241:Aspirin